TY - JOUR
T1 - Geriatric Conditions among Middle-aged and Older Adults on Methadone Maintenance Treatment
T2 - A Pilot Study
AU - Han, Benjamin H.
AU - Cotton, Brandi Parker
AU - Polydorou, Soteri
AU - Sherman, Scott E.
AU - Ferris, Rosie
AU - Arcila-Mesa, Mauricio
AU - Qian, Yingzhi
AU - McNeely, Jennifer
N1 - Publisher Copyright:
Copyright © 2020 American Society of Addiction Medicine.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Objectives:The number of older adults on methadone maintenance treatment (MMT) for opioid use disorder is increasing, but little is known about the characteristics and healthcare needs of this aging treatment population. This population may experience accelerated aging due to comorbidities and health behaviors. The aim of this study was to compare the prevalence of geriatric conditions among adults age ≥50 on MMT to a nationally representative sample of community-dwelling older adults.Methods:We performed a geriatric assessment on 47 adults age ≥50 currently on MMT enrolled in 2 opioid treatment programs, in New York City and in East Providence, Rhode Island. We collected data on self-reported geriatric conditions, healthcare utilization, chronic medical conditions, physical function, and substance use. The results were compared to 470 age, sex, and race/ethnicity-matched adults in the national Health and Retirement Study.Results:The mean age of the study sample was 58.8 years and 23.4% were female. The most common chronic diseases were hypertension (59.6%) and arthritis (55.3%) with 66% reporting ≥2 diseases. For geriatric conditions, adults on MMT had a significantly higher prevalence of mobility, hearing, and visual impairments as well as falls, urinary incontinence, chronic pain, and insomnia than the Health and Retirement Study sample.Conclusions:Older adults on MMT in 2 large opioid treatment programs have a high prevalence of geriatric conditions. An interdisciplinary, geriatric-based approach to care that focuses on function and addresses geriatric conditions is needed to improve the health of this growing population.
AB - Objectives:The number of older adults on methadone maintenance treatment (MMT) for opioid use disorder is increasing, but little is known about the characteristics and healthcare needs of this aging treatment population. This population may experience accelerated aging due to comorbidities and health behaviors. The aim of this study was to compare the prevalence of geriatric conditions among adults age ≥50 on MMT to a nationally representative sample of community-dwelling older adults.Methods:We performed a geriatric assessment on 47 adults age ≥50 currently on MMT enrolled in 2 opioid treatment programs, in New York City and in East Providence, Rhode Island. We collected data on self-reported geriatric conditions, healthcare utilization, chronic medical conditions, physical function, and substance use. The results were compared to 470 age, sex, and race/ethnicity-matched adults in the national Health and Retirement Study.Results:The mean age of the study sample was 58.8 years and 23.4% were female. The most common chronic diseases were hypertension (59.6%) and arthritis (55.3%) with 66% reporting ≥2 diseases. For geriatric conditions, adults on MMT had a significantly higher prevalence of mobility, hearing, and visual impairments as well as falls, urinary incontinence, chronic pain, and insomnia than the Health and Retirement Study sample.Conclusions:Older adults on MMT in 2 large opioid treatment programs have a high prevalence of geriatric conditions. An interdisciplinary, geriatric-based approach to care that focuses on function and addresses geriatric conditions is needed to improve the health of this growing population.
KW - comorbidities
KW - geriatrics
KW - methadone
KW - opioid treatment program
UR - http://www.scopus.com/inward/record.url?scp=85124173543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124173543&partnerID=8YFLogxK
U2 - 10.1097/ADM.0000000000000808
DO - 10.1097/ADM.0000000000000808
M3 - Article
C2 - 33395146
AN - SCOPUS:85124173543
SN - 1932-0620
VL - 16
SP - 110
EP - 113
JO - Journal of Addiction Medicine
JF - Journal of Addiction Medicine
IS - 1
ER -